Study furthers understanding of IBD

Inflammatory Bowel Diseases study

Researchers part-funded by the Medical Research Council (MRC) and the Wellcome Trust have identified how particular parts of the intestinal immune system and the bacteria in the gut can interact to alter an individual's risk of developing Inflammatory Bowel Diseases (IBD). Results are published online today in Immunity.

Using mice, the team led by Professor Graham Lord at King's College London, has shown that a protein called T-bet plays a leading role in maintaining the delicate balance between a healthy immune system and healthy . If researchers can find out how this protein affects inflammation in the intestine, the discovery could eventually pave the way for new ways of treating such as Crohn's disease and ulcerative colitis.

Patients with inflammatory bowel diseases can experience debilitating symptoms and serious complications such as cancer. Patients may require and surgery, and many need to take medication throughout their life to keep their condition under control. Although the causes of IBD remain unknown, most research has pointed to a problem within the intestinal immune system. Normally, the immune system in the gut provides protection from infection; however, in patients with IBD this usually protective function turns against the trillions of that live in the , leading to chronic .

The team has shown that T-bet has a strong influence over the role of inflammation in the intestinal immune system, causing IBD. It had previously been shown that mice with T-bet removed from their immune system spontaneously developed symptoms which mimicked those of IBD in humans. However, this is the first time that scientists have been able to pin down the exact responsible for this process, and to target these cells to reverse the symptoms of IBD in mice. The team had previously shown that T-bet plays a crucial role in deciding how thousands of genes in the body's immune response are controlled.

Professor Graham Lord, Director of the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, says: 'Inflammatory Bowel Diseases in various forms can be painful and debilitating. By improving our understanding of the role that T-bet plays in causing inflammation within the bowel, we will be much better placed to prevent inflammation and establish new lines of attack on these illnesses in the future.'

Professor David Lomas, Chair of the MRC Population and Systems Medicine Board that funded the research, says: 'This research is a clear example of how studying what goes wrong at the molecular level can give crucial insights into how immune diseases such as IBD come about. It's only then that we can begin to intervene and target parts of the immune system before they cause painful and debilitating symptoms. The MRC is committed to funding basic discoveries like this in the laboratory, which can then form part of the vital chain which leads to treatments for patients.'

The article is published in Immunity.

add to favorites email to friend print save as pdf

Related Stories

Novel cytokine protects mice from colitis

Aug 23, 2011

Inflammatory bowel disease (IBD), which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed ...

Recommended for you

Ontario has one of the highest rates of IBD in the world

Aug 28, 2014

One in every 200 Ontarians has been diagnosed with inflammatory bowel disease (IBD), with the number of people living with the disease increasing by 64 per cent between 1999 and 2008, according to a study by researchers at ...

New drug promises relief for inflammatory pain

Aug 27, 2014

Pain from inflammation sidelines thousands of Americans each year. Many face a tough choice: deal with the pain, take a potentially addictive opioid or use a nonsteroidal anti-inflammatory drug that may increase risk for ...

Overweight causes hazardous inflammations

Aug 25, 2014

Researchers have found a possible molecular explanation for why overweight is harmful. This new knowledge may provide new drugs for heart attack, stroke, cancer and chronic intestinal inflammation.

Asthma outcomes worse in older women

Aug 21, 2014

(HealthDay)—Older women face increased challenges in managing their asthma, according to a review published in the August issue of the Annals of Allergy, Asthma & Immunology.

User comments